Name: SRS3392119 - Non-tumor DNA sample from blood of a human female participant in the dbGaP study "CALGB 40601: Randomized Phase III Trial of Paclitaxel Combined With Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer"
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/home/about/policies/

SRS3392119 - Non-tumor DNA sample from blood of a human female participant in the dbGaP study "CALGB 40601: Randomized Phase III Trial of Paclitaxel Combined With Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer" | seqout